Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 317

Similar articles for PubMed (Select 17978289)

1.

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group.

N Engl J Med. 2007 Nov 1;357(18):1810-20. Erratum in: N Engl J Med. 2008 May 1;358(18):1977.

2.

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.

Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, Nashimoto A, Fujii M, Nakajima T, Ohashi Y.

J Clin Oncol. 2011 Nov 20;29(33):4387-93. doi: 10.1200/JCO.2011.36.5908. Epub 2011 Oct 17.

3.

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.

Kinoshita T, Nashimoto A, Yamamura Y, Okamura T, Sasako M, Sakamoto J, Kojima H, Hiratsuka M, Arai K, Sairenji M, Fukushima N, Kimura H, Nakajima T.

Gastric Cancer. 2004;7(2):104-9.

PMID:
15224197
4.

Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002).

Kinoshita T, Sasako M, Sano T, Katai H, Furukawa H, Tsuburaya A, Miyashiro I, Kaji M, Ninomiya M.

Gastric Cancer. 2009;12(1):37-42. doi: 10.1007/s10120-008-0496-1. Epub 2009 Apr 24.

PMID:
19390930
5.

Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer.

Jeong JH, Ryu MH, Ryoo BY, Lee SS, Park I, Lee SH, Kim KC, Yook JH, Oh ST, Kim BS, Kang YK.

Cancer Chemother Pharmacol. 2012 Oct;70(4):523-9. Epub 2012 Aug 5.

PMID:
22864947
6.

Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.

Fujitani K, Tsujinaka T, Hirao M.

Hepatogastroenterology. 2003 May-Jun;50(51):889-92.

PMID:
12828112
7.

Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1.

Aoyama T, Yoshikawa T, Watanabe T, Hayashi T, Ogata T, Cho H, Tsuburaya A.

Gastric Cancer. 2011 Aug;14(3):274-8. doi: 10.1007/s10120-011-0038-0. Epub 2011 Apr 2.

PMID:
21461654
8.

Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.

Lee SJ, Cho SH, Yoon JY, Hwang JE, Bae WK, Shim HJ, Chung IJ.

Cancer Chemother Pharmacol. 2009 Dec;65(1):159-66. doi: 10.1007/s00280-009-1019-4. Epub 2009 May 29.

PMID:
19479256
9.

S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.

Takahashi I, Kakeji Y, Emi Y, Sakurai M, Yonemura Y, Kimura Y, Maehara Y.

Gastric Cancer. 2003;6 Suppl 1:28-33.

PMID:
12775017
10.

Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.

Inoue T, Yachida S, Usuki H, Kimura T, Hagiike M, Okano K, Suzuki Y.

Ann Surg Oncol. 2012 Sep;19(9):2937-45. doi: 10.1245/s10434-012-2332-4. Epub 2012 Mar 31.

PMID:
22466666
11.

A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC).

Ueda Y, Fujimura T, Kinami S, Hirono Y, Yamaguchi A, Naitoh H, Tani T, Kaji M, Yamagishi H, Miwa K; Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC).

Jpn J Clin Oncol. 2006 Aug;36(8):519-22. Epub 2006 Jun 27.

12.

Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey.

Kawai H, Ohtsu A, Boku N, Hamamoto Y, Nagashima F, Muto M, Sano Y, Mera K, Yano T, Doi T, Yoshida S.

Gastric Cancer. 2003;6 Suppl 1:19-23.

PMID:
12775015
13.

Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial.

Tatebe S, Tsujitani S, Nakamura S, Shimizu T, Yamane N, Nishidoi H, Kurisu Y, Kanayama H, Ogawa H, Ikeguchi M.

Gastric Cancer. 2014;17(3):508-13. doi: 10.1007/s10120-013-0289-z. Epub 2013 Aug 15.

PMID:
23948997
14.

Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.

Aoyama T, Yoshikawa T, Hayashi T, Kuwabara H, Mikayama Y, Ogata T, Cho H, Tsuburaya A.

Ann Surg Oncol. 2012 May;19(5):1568-74. doi: 10.1245/s10434-011-2158-5. Epub 2011 Dec 6.

PMID:
22143578
15.

Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.

Okuyama T, Korenaga D, Edagawa A, Itoh S, Oki E, Kawanaka H, Ikeda Y, Kakeji Y, Tateishi M, Tsujitani S, Takenaka K, Maehara Y.

Surg Today. 2012 Aug;42(8):734-40. doi: 10.1007/s00595-012-0129-5. Epub 2012 Jan 27.

PMID:
22278622
16.

Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer.

Kochi M, Fujii M, Kanamori N, Kaiga T, Takahashi T, Kobayashi M, Takayama T.

J Cancer Res Clin Oncol. 2006 Dec;132(12):781-5. Epub 2006 Jun 28.

PMID:
16804723
17.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M.

Lancet Oncol. 2008 Mar;9(3):215-21. doi: 10.1016/S1470-2045(08)70035-4. Epub 2008 Feb 20.

PMID:
18282805
18.

[Clinical study of S-1 for advanced gastric cancer after reduction surgery].

Inaba Y, Hayashi K, Miura T, Moriya T, Takiguchi M, Isobe H, Watabe S.

Gan To Kagaku Ryoho. 2007 Jul;34(7):1053-7. Japanese.

PMID:
17637541
19.

[Examination of s-1 therapy for adjuvant chemotherapy in patients with advanced gastric cancer].

Matsui K, Nashimoto A, Yabusaki H, Nakagawa S, Nomura T, Takii Y, Tsuchiya Y, Tanaka O.

Gan To Kagaku Ryoho. 2009 Jun;36(6):953-7. Japanese.

PMID:
19542714
20.

A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703).

Kodera Y, Ishiyama A, Yoshikawa T, Kinoshita T, Ito S, Yokoyama H, Mochizuki Y, Ito H, Tsuburaya A, Sakamoto J, Nakao A; Chubu Clinical Cancer Group.

Gastric Cancer. 2010 Aug;13(3):197-203. doi: 10.1007/s10120-010-0559-y. Epub 2010 Sep 5.

PMID:
20820990
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk